
Digital Surgery, How George Murgatroyd GM & VP of Medtronic Sees AI Transforming the OR!
The podcast features George Murgatroyd, Medtronic’s VP of Digital Technologies, discussing how artificial intelligence is poised to transform the operating room. He argues that current practices—surgeons still relying on USB sticks and DVDs for case review—are obsolete, and that high‑compute AI can automatically capture, analyze, and deliver surgical footage for performance improvement. Key insights include the need for powerful AI infrastructure to digitize every step of a procedure, the emergence of AI‑driven tools such as Medtronic’s “Donna” that automate sales and data entry, and the stark financial reality that hospitals operate on margins as thin as 2%. These cost pressures make scaling innovative digital solutions difficult, even as the technology promises to reduce long‑term expenses. Murgatroyd illustrates his points with vivid examples: he likens the regulatory lag in driverless cars to the healthcare sector’s slow adoption, cites surgeons’ reliance on outdated media, and emphasizes that “you can’t replace them the same”—meaning AI will augment, not replace, surgeons. He also shares a personal anecdote about his varied career path, underscoring the cultural shift needed within the industry. The implications are profound. AI could democratize surgical quality, shifting surgeon value toward bedside manner while technology handles routine analysis. For medtech firms, the challenge is delivering affordable, scalable solutions that align with hospital economics. Successful adoption could improve patient outcomes, lower costs, and reshape the future skill set of surgeons.

MD&M 2026 Keynote: $6.1B Advice From Ray Cohen and Tom West!
The MD&M West 2026 keynote, titled “Disrupting the Status Quo: Are We Innovating or Just Iterating?”, brought together veteran deal‑maker Ray Cohen and former J&J executive Tom West to debate what true innovation looks like in medical technology. Cohen warned that...

Trump MRI Debate and Longevity Scans with Sean O'Mara and Daniel J. Durand of Prenuvo
The episode centers on President Trump’s recent executive MRI and its broader implications for preventive health, featuring insights from Dr. Daniel Durand, Chief Medical Officer at Prenuvo, and Dr. Shawn Omera, a physician‑researcher focused on visceral fat and longevity. The...

The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson.
The episode spotlights the launch of "The Book of Elon," authored by Eric Jorgenson, a veteran curator of tech‑leader wisdom. Jorgenson, now CEO of Scribe Media, explains how the book distills Elon Musk’s relentless focus, first‑principles engineering, and audacious purpose...

Why Most People Fail at Listening and How to Fix It!
The video, hosted by Omar M. Katib, tackles why most people fail at listening and offers a framework to turn listening into a strategic advantage for sales, fundraising, and leadership. Katib distinguishes real listening—driven by the intent to understand, enjoy, learn,...

Venture:How Olympus Innovation Ventures Invests in MedTech Startups with Abby Hunter Syed
Olympus Innovation Ventures (OIV), the corporate venture arm of Olympus, is actively investing in MedTech startups focused on endoscopy, diagnostics, and digital health, as explained by director Abby Hunter‑Syed. The discussion highlights OIV’s strategic approach—prioritizing founder conviction, transparent founder‑investor relationships,...

US Surgical: VP of R&D Kurt Azarbarzin on Scaling Product and Innovation of a Billion Dollar Empire
The interview with Kurt Azarbarzin, US Surgical’s longtime VP of R&D, chronicles how the company grew from a modest stapler maker in the early 1980s into a multi‑billion‑dollar empire that helped define modern laparoscopic surgery. Azarbarzin describes the shift from open...

US Surgical's $1 Billion Lesson and the Laparoscopic Revolution of the 90s
US Surgical’s 1990s laparoscopic revolution was ignited when senior director Lee Cohen uncovered an illegal off‑label experiment and convinced CEO Leon Hirsch to stake the entire company on the technology. The bold "Green Beret" sales force trained roughly 40,000 surgeons,...

US Surgical’s Founding History: How Leon Hirsch Built Medicine’s Most Infamous Device Company Now!
US Surgical, founded by high‑school dropout Leon C. Hirsch, transformed a niche Russian surgical device into a 90% market monopoly that defined modern minimally invasive surgery. Hirsch risked his life savings, built the aggressive "Organ Grinder" sales training, and deployed...